Mitsui Chemicals to Re-Enter Nucleic Acid Drug CDMO Market Mar. 7, 2022 Filed Under: Pharma Tagged With: CDMO, Mitsui Chemicals, nucleic acid drugsMitsui Chemicals Inc. (TYO:4183) plans to get back involved in the CDMO business for nucleic acid drugs. By 2025, the…... Please subscribe to read the full story. Subscribe Free Trial Related Articles:NOF to Invest Big in DDS Materials in Anticipation of…Japan Looks to Catch the West as Opportunities Open up for…NOF Moves to Boost Production of DDS Materials for…Sumitomo Chemical Eyes Mass Production of Nucleic Acid Drug…Daicel Targets 2024 for Launch of Centralized Medical…Microwave Chemical Looks to Apply Microwave Technologies to…